On November 15, 2021 TG Therapeutics, Inc. (NASDAQ: TGTX), reported that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat during the Jefferies London Healthcare Conference, taking place virtually November 18 – 19, 2021 (Press release, TG Therapeutics, NOV 15, 2021, View Source [SID1234595622]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The fireside chat will be available for on demand download through the Jefferies conference platform beginning at 8:00am GMT / 3:00am ET on Thursday, November 18, 2021. The fireside chat will also be available on the Events page, located within the Investors & Media section, of the Company’s website at View Source, beginning on November 18, 2021 and for a period of 30 days after the event.